Concise summaries of everything published in the latest weekly issue of the New England Journal of Medicine (NEJM). NEJM publishes new medical research findings, review articles, and editorial opinion on topics of importance to biomedical science and clinical practice.
…
continue reading
NEJM AI Grand Rounds, hosted by Arjun (Raj) Manrai, Ph.D. and Andrew Beam, Ph.D., features informal conversations with a variety of unique experts exploring the deep issues at the intersection of artificial intelligence, machine learning, and medicine. You’ll learn how AI will change clinical practice and healthcare, how it will impact the patient experience, and about the people who are pushing for innovation. Whether you are an AI researcher or a practicing clinician, these conversations w ...
…
continue reading
Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.
…
continue reading
Audio podcasts featuring the week’s top medical news plus pertinent interviews
…
continue reading
This podcast from NEJM Catalyst features interviews with leaders in health care as they discuss innovative ideas and actionable solutions for enhancing the value of health care delivery, providing perspectives on what's working in the industry, what's not, and why.
…
continue reading
Audio podcasts featuring the week’s top medical news plus pertinent interviews
…
continue reading
The House reflects medicine’s most pressing issues through the eyes of residents, providing a forum to share their stories from the bedside, where they are learning far more than the lessons of clinical medicine.
…
continue reading
This podcast from NEJM Resident 360 takes a deep dive into key topics with expert clinicians and educators. As we explore the details of pathophysiology and critique the evidence behind clinical practice, these conversations are intended to give you better understanding of the topic and greater confidence when treating your patients.
…
continue reading
A Day in the Life is a podcast for medical students, by medical students. Interviews with attendings about daily life and training may help you explore a range of specialties.
…
continue reading
General Medicine Podcast which keeps you up to date with the latest and greatest medical literature.
…
continue reading
Core IM Podcast
…
continue reading
Community Health Center
…
continue reading
The Critical Care Commute Podcast is grateful for your ears, insights and feedback. In return its hosts- Peter Brindley and Leon Byker, two ICU doctors in Alberta, Canada- offer up knowledge and debate with some of the most qualified, interesting, enlightened and provocative folks in Critical Care Medicine, and beyond. We strive to keep it practical and concise. Like you, our overriding goal is to get better, do better and feel better.
…
continue reading
Core Internal Medicine via following series: 5 Pearls || Clinically relevant pearls Mind the Gap || Why do we do what we do? Gray Matters || Management Reasoning Hoofbeats || Dissecting clinical reasoning At the Bedside || Explore everyday challenges
…
continue reading
my life, my struggle
…
continue reading
MedPod Today is a podcast from MedPage Today where leading healthcare professionals and our seasoned reporters discuss the latest news and trends in the medical world. The podcast will feature diverse content, from our poignant medical story-telling show, Anamnesis, to reporter roundtables where our writers dive deeper into some of our most compelling healthcare stories. The podcast will also spotlight clinician conversations with our Editor-In-Chief, Jeremy Faust, MD.
…
continue reading
Doctors and other health care professionals are too often socialized and pressured to become “efficient task completers” rather than healers, which leads to unengaged and unimaginative medical practice, burnout, and diminished quality of care. It doesn’t have to be that way. With a range of thoughtful guests, co-hosts Saul Weiner MD and Stefan Kertesz MD MS, interrogate the culture and context in which clinicians are trained and practice for their implications for patient care and clinician ...
…
continue reading
Welcome to the The med files podcast. I’ll be discussing various topics of medicine. It’s gonna be fun.
…
continue reading
Let's talk about contemporary issues in cardiology. Let's discuss and learn together. Join me in this quest for knowledge in cardiology.
…
continue reading
1
NEJM Interview: Jose Figueroa on the potential effects of the results of the 2024 elections on health care access, affordability, and equity.
21:26
21:26
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
21:26
Jose Figueroa is an associate professor of health policy and management at the Harvard T.H. Chan School of Public Health and an assistant professor of medicine at Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.M. McWilliams and S.B. Dusetzina. Affordability of Health Care in the United…
…
continue reading
Featuring articles on nivolumab in advanced Hodgkin’s lymphoma, kidney transplantation from donors with HIV, a modular communicative leadless pacing–defibrillator system, stereotactic body radiotherapy in prostate cancer, and on how DNA sensing drives inflammation; a review article on cryoglobulinemia; a case report of a woman with dyspnea, dysphag…
…
continue reading
1
The Pulse of Progress: AI in Cardiology with Dr. David Ouyang
50:23
50:23
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
50:23
In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Dr. David Ouyang, a cardiologist and AI researcher at Cedars-Sinai Medical Center. The conversation explores Ouyang’s journey from medical training to AI research and entrepreneurship, his groundbreaking work in applying AI to cardiology imaging, and the challenges of…
…
continue reading
Time Stamps 01:29 History of Transfusion Guidelines/Studies 06:49 Pathophysiology of Anemia in heart disease 10:04 Transfusion in MI Studies 13:45 MINT Trial 22:20 Takeaways/Discussion Sponsor: Freed is an AI scribe that listens, prepares your notes, and writes your note in < 30 seconds. Freed learns your style over time and is HIPAA compliant! Joi…
…
continue reading
1
#161 Transfusion Thresholds and the MINT Trial: Beyond Journal Club with NEJM Group
29:34
29:34
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
29:34
Can the MINT trial change how we treat anemia in acute MI? The largest trial of its kind compared liberal vs. restrictive transfusion strategies in patients with myocardial infarction. Sponsor: Freed is an AI scribe that listens and writes your note in < 30 seconds. Freed learns your style over time and is HIPAA compliant! Use the code CORE50 to ge…
…
continue reading
Previous Next Time Stamps 01:20 Case 1 18:46 Case 2 Sponsor: Glass Health The most loved feature on Glass Health is the Ddx feature that helps you expand your differential using A.I! Use core COREIM for one month free access of AI queries through Glass Pro. Show Notes Transitioning to hospice A hospitalized patient elects to enroll in hospice, now …
…
continue reading
What if a patient can't afford hospice? Which medications do you deprescribe when on hospice? What happens when patients who are on hospice return to the hospital or ED? Behind the Scenes Youtube Interview: Hospice Music Therapy Show notes & Transcript Hospice 101 Episode 1 Sponsor: Imagine leveraging A.I to do pre-charting before seeing a patient.…
…
continue reading
1
“Simonisms”: Revisiting the uncommon wisdom of a physician and educator who shaped us deeply
34:01
34:01
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
34:01
To commemorate the start of our fifth season, we revisit a conversation we had almost two years ago about the wisdom of Simon Auster, MD. Simon was a family physician and psychiatrist who inspired the conversations we’ve been having with each other and with guests on every episode. “Simonisms” embody Simon’s insights: pithy observations about the p…
…
continue reading
1
Trump vs. Harris on Health Care: Experts Explain Each Side
32:32
32:32
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
32:32
Originally broadcast October 10, 2024 The countdown is on to election day with health care issues hanging in the balance as never before. The biggest one: Abortion and reproductive rights. Andrea Ducas, the Vice President of Health Policy at the Center for American Progress, says “What you see with Vice President Harris is a candidate who’s committ…
…
continue reading
1
CDC Director Warns of More Dangers From Hurricane Helene
29:00
29:00
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
29:00
Originally broadcast October 2, 2024 U.S. Centers for Disease Control and Prevention Director Dr. Mandy Cohen described to “Conversations on Health Care” that their role right now is ensuring impacted residents understand the health risks that are present and could continue to grow in the aftermath of Hurricane Helene. Dr. Cohen says while local, s…
…
continue reading
1
Trump & Harris Debate IVF: Why It’s an Election Issue
29:00
29:00
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
29:00
Originally broadcast September 26, 2024 At the beginning of this year, few could have predicted that in vitro fertilization would become a big political topic. But that’s what occurred after the Alabama Supreme Court ruled frozen embryos are “unborn children.” The Alabama legislature then responded by passing a law to shield IVF providers. Since th…
…
continue reading
1
NEJM Interview: Jean Nachega on the mpox Public Health Emergency of International Concern.
9:20
9:20
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
9:20
Jean Nachega is an associate professor of infectious diseases and microbiology and of epidemiology at the University of Pittsburgh School of Public Health and a professor of medicine at Stellenbosch University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.B. Nachega and Others. Mpox in Pregnancy — Risks, Ve…
…
continue reading
Featuring articles on beta-blocker use after myocardial infarction and treatments for cerebral adrenoleukodystrophy and for small-cell lung cancer; a review article on hairy-cell leukemia; a case report of a man with fever, myalgia, jaundice, and respiratory failure; and Perspectives on Mpox, on addressing health care cost growth, and on confirmato…
…
continue reading
1
NEJM Interview: Jonathan Oberlander on the implications of the 2024 U.S. elections for health care reform.
8:47
8:47
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
8:47
Jonathan Oberlander is a professor of social medicine and of health policy and management at the University of North Carolina at Chapel Hill. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Oberlander. Health Care Reform and the 2024 U.S. Elections — Low Visibility, High Stakes. N Engl J Med 2024;391:1169-117…
…
continue reading
Featuring articles on lenacapavir for HIV prevention in cisgender women, tirzepatide for treatment of obstructive sleep apnea, lymphadenectomy for muscle-invasive bladder cancer, secondary T-cell lymphoma after CAR T-cell therapy, and immunity and early colorectal carcinogenesis; a review article on prolonged grief disorder; a Clinical Problem-Solv…
…
continue reading
1
Ferguson and Scales on Research and Conferences
24:44
24:44
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
24:44
In this episode, we sit down with Dr. Damon Scales and Dr. Niall Ferguson at the Canadian Critical Care Forum. We dive into a little bit of ARDS and spend a whole lot of time talking about the evolving landscape of conferences and critical care research. Tune in for insights from two leaders in the field!…
…
continue reading
1
MedPod Today: New COVID Variant; FDA Eye Drop Warning; CRNA Scope Creep?
11:00
11:00
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
11:00
MedPod Today: the podcast series where MedPage Today reporters share deeper insight into the week's biggest healthcare stories. This week, MedPage Today reporters discussa new COVID variant, why the FDA is concerned about amniotic fluid in eyedrops, conversations happening in California about certified registered nurse anesthetists’ scope of practi…
…
continue reading
1
NEJM Interview: Abigail Cutler on providing training in abortion care to Ob/Gyn residents amid legal restrictions.
10:12
10:12
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
10:12
Abigail Cutler is an assistant professor and associate residency program director in the Department of Obstetrics and Gynecology at the University of Wisconsin School of Medicine and Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.S. Cutler and E. Hartenbach. Dobbs Revisited — Addressing Effects…
…
continue reading
Featuring articles on systematic vs. targeted biopsy for prostate cancer screening, ziresovir in hospitalized infants with RSV, gene therapy for factor IX deficiency, and a phase 2 trial of tulisokibart for ulcerative colitis; a review article on neuroleptic malignant syndrome; a case report of a woman with kidney lesions and lytic bone disease; an…
…
continue reading
1
Mark Cuban: Drug Price Disrupter Explains How It Works
29:00
29:00
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
29:00
Originally broadcast November 22, 2022 When we have a guest like “Shark Tank” star Mark Cuban, it’s can be hard to keep up with all his thoughts. He was a bundle of energy in November 2022 explaining his then-new venture trying to reform how Americans can purchase lower-priced drugs; he called it “dunking on the pharma industry.” Since our conversa…
…
continue reading
1
NEJM Interview: Charles Weijer on the potential benefits and ethical challenges associated with pragmatic and cluster RCTs.
11:56
11:56
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
11:56
Charles Weijer is a professor in the Departments of Medicine and Philosophy at Western University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. C. Weijer and M. Taljaard. Ethical Challenges Associated with Pragmatic and Cluster RCTs. N Engl J Med 2024;391:969-971.…
…
continue reading
Featuring articles on long-term oxygen therapy in severe hypoxemia, reducing opioid overdose deaths, blocking CSF1R in chronic GVHD, and pomalidomide in hereditary hemorrhagic telangiectasia; a review article on central nervous system vasculitis; a case report of a man with confusion and kidney failure; a Medicine and Society on house staff unioniz…
…
continue reading
1
AI at the Frontlines: Dissecting Clalit’s Roadmap for the Future of Public Health with Noa Dagan and Ran Balicer
1:11:23
1:11:23
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:11:23
In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Dr. Noa Dagan and Dr. Ran Balicer from the Clalit Research Institute in Israel. The conversation explores Clalit’s groundbreaking work in implementing predictive models at the point of care, their contributions to COVID-19 research, and the potential of AI in revoluti…
…
continue reading
Time Stamps 01:07 Strategies for Moral Distress 09:25 Strategies for Addressing Moral Injury 20:52 Conclusion Show Notes INTRO Beth Epstein, PhD, RN, HEC-C, FAAN Wendy Dean, MD STRATEGIES FOR ADDRESSING MORAL DISTRESS Acknowledgement & validation of concerns First recognizing it yourself Seek out colleagues to clarify/verify experiences Not a YOU p…
…
continue reading
1
#160 Moral Distress Part 2: At the Bedside Segment
25:44
25:44
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
25:44
Strategies to address moral distress and moral injury — hear from the experts on their work on the topic! Timestamps: (01:07) | Strategies for Addressing Moral Distress (09:25) | Strategies for Address Moral Injury (20:52) | Conclusion Transcript and Show notes Tags: IMCore, CorelM, Burnout, Moral Distress, Moral Injury, Moral Residue, Medical Huma…
…
continue reading
1
Do the doctors who sold Matthew Perry ketamine indicate something rotten in mainstream medicine?
57:24
57:24
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
57:24
The two doctors charged for their roles in the events leading up to actor Matthew Perry’s death were both involved in a “side hustle”: selling ketamine at a big mark-up to make extra money, above what they earned through legitimate practice. One was an internist-pediatrician and the other an emergency medicine physician. Their cynicism was starkly …
…
continue reading
1
NEJM at ESMO — Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine Tumors
2:56
2:56
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
2:56
Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM at ESMO — Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma
2:58
2:58
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
2:58
Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM at ESMO — Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
3:25
3:25
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
3:25
Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM at ESMO — Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
3:44
3:44
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
3:44
Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM at ESMO — Overall Survival with Pembrolizumab in Early-Stage Triple- Negative Breast Cancer
3:23
3:23
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
3:23
Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM at ESMO — Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
3:11
3:11
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
3:11
Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading
1
NEJM at ESMO — Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
3:41
3:41
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
3:41
Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
…
continue reading